Last Updated : December 20, 2011
Details
FilesGeneric Name:
Apixaban
Project Status:
Complete
Therapeutic Area:
Venous thromboembolic events, prevention
Manufacturer:
Bristol-Myers Squibb and Pfizer Canada Alliance
Call for patient/clinician input open:
Brand Name:
Eliquis
Project Line:
Reimbursement Review
Project Number:
SR0264-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Thromboembolic events, (venous) prevention
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : December 20, 2011